Skip to main content
FUSION ANTIBODIES PLC logo

FUSION ANTIBODIES PLC — Investor Relations & Filings

Ticker · FAB ISIN · GB00BDQZGK16 LEI · 213800KBAYRC9VOQ9V39 IL Professional, scientific and technical activities
Filings indexed 301 across all filing types
Latest filing 2021-09-24 AGM Information
Country GB United Kingdom
Listing IL FAB

About FUSION ANTIBODIES PLC

https://www.fusionantibodies.com/

Fusion Antibodies PLC is a contract research organization (CRO) that provides a comprehensive suite of services for the discovery, engineering, and supply of preclinical biologics. The company offers an integrated, end-to-end antibody development platform, spanning from initial antigen design and antibody generation to advanced engineering processes like humanization and affinity maturation. It also provides services for the supply of recombinant proteins and antibodies, including stable cell line development. Fusion Antibodies supports therapeutic and diagnostic programs, operating as a collaborative partner to guide projects through critical preclinical stages with a focus on long-term manufacturability and commercialization.

Recent filings

Filing Released Lang Actions
Result of AGM
AGM Information Classification · 99% confidence The document is a regulatory announcement identified by the 'RNS Number' header and the closing statement referencing RNS as the news service of the London Stock Exchange. The core content explicitly states the 'Result of AGM' and confirms that 'all resolutions were duly passed'. This directly relates to the outcome of an Annual General Meeting. Although it mentions where the full details will be available, the document itself is the official announcement of the AGM results, which aligns best with the 'Declaration of Voting Results & Voting Rights Announcements' (DVA). It is not the AGM presentation (AGM-R) or a proxy solicitation document (PSI).
2021-09-24 English
AGM Statement
AGM Information Classification · 99% confidence The document is explicitly titled "AGM statement" and announces that a statement from the Chair will be read at the "AGM due to be held at 11am today." This content directly relates to the Annual General Meeting proceedings and materials. Therefore, the appropriate classification is AGM Information (AGM-R). The document length (5803 chars) is substantial enough to be the statement itself, not just a brief announcement of a report.
2021-09-24 English
Notice of AGM
AGM Information Classification · 98% confidence The document explicitly states 'Notice of AGM' and mentions that the company is 'posting to shareholders a copy of the Company's annual report and accounts for the year ended 31 March 2021 ("Accounts") and notice of the Company's annual general meeting ("AGM")'. This indicates the primary purpose is related to the Annual General Meeting. Although it mentions the Annual Report (10-K content), the document itself is the formal notice and announcement concerning the AGM. Given the options, AGM-R (AGM Information) is the most specific and accurate classification for a notice of an AGM, even though it references the Annual Report.
2021-09-01 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is identified by the header 'RNS Number' and contains information about the company's 'Total Voting Rights' as of a specific date (31 August 2021). This type of announcement, which provides a mandatory regulatory update regarding the total number of shares and voting rights (often used as the denominator for disclosure calculations under FCA rules), is a standard regulatory notification. Since it is a specific regulatory announcement that doesn't fit the definitions for Director's Dealing (DIRS), Major Shareholding Notification (MRQ), or Dividend Notice (DIV), and it is not a full report, the most appropriate classification is the general regulatory filing category, RNS, as it is explicitly sourced from RNS and serves a regulatory disclosure function.
2021-08-31 English
Collaboration with Eurofins Discovery
Regulatory Filings Classification · 100% confidence The document is explicitly labeled as an "RNS Number" and contains a section titled "Reach - non regulatory announcement". It details a commercial collaboration agreement between Fusion Antibodies plc and Eurofins Discovery. The document concludes with a section explaining that 'Reach' is a non-regulatory press release distribution service, distinguishing it from formal regulatory announcements (RNS regulatory announcement). Since this is a general business update that is explicitly non-regulatory and distributed via the RNS distribution service, it fits best under the general 'Regulatory Filings' (RNS) category, which serves as the fallback for miscellaneous, non-core regulatory announcements, especially those explicitly marked as non-regulatory news releases distributed through the RNS infrastructure.
2021-08-24 English
Exercise of Options and Total Voting Rights
Share Issue/Capital Change Classification · 99% confidence The document is identified by the RNS Number header and contains an announcement dated August 10, 2021, regarding the 'Exercise of Options and Total Voting Rights'. Specifically, it details the issuance of new ordinary shares due to option exercises and updates the total voting rights figure (25,894,946 shares) for shareholders to use under FCA Disclosure Guidance. This type of announcement, which relates to changes in share capital structure and voting rights following internal events (like option exercises), fits best under the 'Share Issue/Capital Change' (SHA) category, or potentially 'Regulatory Filings' (RNS) as a general announcement. Since the core content is about the resulting share capital change and the notification of the new total voting rights denominator, SHA is more specific than RNS. However, the document is clearly a regulatory news service (RNS) announcement, which often covers share changes. Given the options, 'SHA' covers the substance (share issue/capital change), while 'RNS' covers the format/source (general regulatory announcement). Since the content is a specific notification about share issuance and the resulting total voting rights, SHA is the most precise fit among the specific categories. If the document were purely a notification that a report was available, RPA would be chosen. Here, the information itself is the announcement of the capital change. I will classify it as SHA, as it directly addresses a change in the number of shares and voting rights.
2021-08-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.